Restore Flow Allografts Overview

  • Founded
  • 2013
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $18M
Latest Deal Amount

Restore Flow Allografts General Information

Description

Developer of human tissue preservation company designed for restorative transplantation of donated human tissue for medical treatment. The company offers saphenous vein, femoral vein and femoral artery, aortoiliac artery for transplantation of donated human vascular allograft tissue and other medical treatment, enabling patients with safe vascular allograft and control infection.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Primary Office
  • 912 Northwest Highway
  • Fox River Grove, IL 60021
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Restore Flow Allografts Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 10-Nov-2016 $18M 0000 Completed Profitable
1. Early Stage VC Completed Generating Revenue
To view Restore Flow Allografts’s complete valuation and funding history, request access »

Restore Flow Allografts Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CV Ventures Venture Capital Minority 000 0000 000000 0
To view Restore Flow Allografts’s complete investors history, request access »